(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 0.85% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Quidelortho's revenue in 2025 is $2,782,900,000.On average, 4 Wall Street analysts forecast QDEL's revenue for 2025 to be $182,643,892,221, with the lowest QDEL revenue forecast at $182,011,243,638, and the highest QDEL revenue forecast at $183,252,260,048. On average, 4 Wall Street analysts forecast QDEL's revenue for 2026 to be $190,584,711,079, with the lowest QDEL revenue forecast at $189,254,327,999, and the highest QDEL revenue forecast at $192,632,050,922.
In 2027, QDEL is forecast to generate $199,916,277,674 in revenue, with the lowest revenue forecast at $199,916,277,674 and the highest revenue forecast at $199,916,277,674.